Targeted Therapies in Sarcomas: Challenging the Challenge
Figure 2
The activation of IGFR by ligand binding triggers a signal transduction pathway that causes the activation of mTOR pathway and inhibition of apoptosis, thus promoting cell survival. Anti-IGFR antibodies prevent this effect.